Faculty Lecture: 'Role of macrophages in the initiation and maintenance of fibrosis'
Wednesday 25 June 4pm, Dental Lecture Theatre F
Guest Speaker: Dr Tom Wynn, senior investigator and chief of the Immunopathogenesis Section of the Laboratory of Parasitic Disease
Dr. Wynn is a senior investigator and chief of the Immunopathogenesis Section of the Laboratory of Parasitic Disease. He also serves as the scientific director of the NIH-Oxford-Cambridge Scholars program, a doctoral training program for outstanding science students committed to biomedical research, which annually supports more than 52 doctoral candidates at NIH, Oxford University, and Cambridge University. Dr. Wynn obtained his Ph.D. from the University of Wisconsin-Madison Medical School in the department of microbiology and immunology. His laboratory group uses a variety of in vivo model systems to study the immunological mechanisms controlling chronic inflammation and fibrosis. He has published over 175 papers, reviews, and book chapters in many prestigious journals, including Nature, Nature Immunology, Journal of Experimental Medicine, Gastroenterology, Nature Reviews Immunology, Nature Medicine, and Annual Review of Immunology. He has made seminal contributions to our understanding of the role of IL-13, IL-17A, and macrophages in the progression and resolution of liver and lung fibrosis and has developed in vivo models to test novel anti-fibrotic drugs. Dr. Wynn was recently elected to fellowship in the American Academy of Microbiology and has received several prestigious awards, including the Bailey K. Ashford Medal from the American Society of Tropical Medicine and Hygiene, the Oswaldo Cruz Medal from the Oswaldo Cruz Foundation, and two Merit Awards from NIH. Dr. Wynn has organized several national and international scientific meetings, including three Keystone Symposia, and collaborates extensively with the pharmaceutical industry.